2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Weight Loss
1
Pancreatic Neoplasms
1
Hematologic Neoplasms
1
Disease
1
Cachexia
1
Adenocarcinoma
1
Interventions
Megestrol Acetate
9
Exercise
6
Standard of Care
4
Blood Specimen Collection
4
Olanzapine
3
Ibuprofen
3
dermcidin
2
anamorelin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Infliximab
2
Enteral Nutrition
2
Dietary Supplements
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
telotristat ethyl
1
remune
1
ostarine
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
clazakizumab
1
bermekimab
1
alkaloid GB18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cachexia
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled